Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Carfilzomib/dexamethasone/lenalidomide

Cardiac failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a single-center retrospective study of 29 patients, a 76-year-old man was described, who developed cardiac failure during treatment with carfilzomib, dexamethasone and lenalidomide for multiple myeloma. …
Literatur
Zurück zum Zitat Okazuka K, et al. Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients. Rinsho Ketsueki 59: 698-700, No. 6, 2018. Available from: URL: http://doi.org/10.11406/rinketsu.59.698 [Japanese; summarised from a translation] -Japan Okazuka K, et al. Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients. Rinsho Ketsueki 59: 698-700, No. 6, 2018. Available from: URL: http://​doi.​org/​10.​11406/​rinketsu.​59.​698 [Japanese; summarised from a translation] -Japan
Metadaten
Titel
Carfilzomib/dexamethasone/lenalidomide
Cardiac failure: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65849-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Antineoplastics

Case report

Antimicrobials

Case report

Rivastigmine